retatrutide glp 1 Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA The GLP-1s-Semaglutide, Tirzepatide & Retatrutide:

investigated the effects of KRH102053 (2-amino-4-methylsulphanyl-butylic acid-4-methoxy-6-(4-methoxy-benzylamino)-2, 2-dimethyl-chroman-3-yl ester), a novel small-molecule activator of PHD2, in human HOS osteosarcoma, rat PC12 phaeochromocytoma and human HepG2 hepatoma cells

But with a lot of attention comes a lot of misinformation, misunderstandings, and concerns

Cell Cycle 15 , 7283 (2016)

These peptides could offer therapeutic and preventive benefits for conditions like benign prostatic hyperplasia and prostatitis

At the same time, GLP-1 receptor activation reduces the activity of pathogenic Th1 and Th17 cells, the effector T cells most directly responsible for autoimmune tissue damage